The Gross Margin of Suven Pharmaceuticals Ltd (SUVENPHAR.NS) is 58.85%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-03-31 | 58.85% |
| 2023-03-31 | 57.60% |
| 2022-03-31 | 58.32% |
| 2021-03-31 | 58.87% |
| 2020-03-31 | 61.66% |
| 2019-03-31 | 62.23% |